Cargando…

Evaluation of a Gel Containing a Propionibacterium Extract in an In Vivo Model of Wound Healing

Inappropriate wound healing (WH) management can cause significant comorbidities, especially in patients affected by chronic and metabolic diseases, such as diabetes. WH involves several different, partially overlapping processes, including hemostasis, inflammation, cell proliferation, and remodeling...

Descripción completa

Detalles Bibliográficos
Autores principales: M., Campolo, G., Gallo, F., Roviello, A., Ardizzone, M., La Torre, A., Filippone, M., Lanza, S., Cuzzocrea, L., Siroli, E., Esposito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101165/
https://www.ncbi.nlm.nih.gov/pubmed/35563099
http://dx.doi.org/10.3390/ijms23094708
_version_ 1784707019223072768
author M., Campolo
G., Gallo
F., Roviello
A., Ardizzone
M., La Torre
A., Filippone
M., Lanza
S., Cuzzocrea
L., Siroli
E., Esposito
author_facet M., Campolo
G., Gallo
F., Roviello
A., Ardizzone
M., La Torre
A., Filippone
M., Lanza
S., Cuzzocrea
L., Siroli
E., Esposito
author_sort M., Campolo
collection PubMed
description Inappropriate wound healing (WH) management can cause significant comorbidities, especially in patients affected by chronic and metabolic diseases, such as diabetes. WH involves several different, partially overlapping processes, including hemostasis, inflammation, cell proliferation, and remodeling. Oxidative stress in WH contributes to WH impairment because of the overexpression of radical oxygen species (ROS) and nitrogen species (RNS). This study aimed to evaluate the in vitro antioxidative action of a gel containing a Propionibacterium extract (Emorsan(®) Gel) and assess its skin re-epithelialization properties in a mouse model of WH. The scavenging effects of the bacterial extract were assessed in vitro through the ABTS and DPPH assays and in L-929 murine fibroblasts. The effects of the Emorsan(®) Gel were studied in vivo in a murine model of WH. After WH induction, mice were treated daily with vehicle or Emorsan(®) Gel for 6 or 12 days. According to the in vitro tests, the Propionibacterium extract exerted an inhibitory effect on ROS and RNS, consequently leading to the reduction in malondialdehyde (MDA) and nitrite levels. Before proceeding with the in vivo study, the Emorsan(®) Gel was verified to be unabsorbed. Therefore, the observed effects could be ascribed to a local action. The results obtained in vivo showed that through local reduction of oxidative stress and inflammation (IL-1β, TNF-α), the Emorsan(®) Gel significantly reduced the infiltration of mast cells into the injured wound, leading to the amelioration of symptoms such as itch and skin irritation. Therefore, the Emorsan(®) Gel improved the speed and percentage of wound area closure by improving the tissue remodeling process, prompting vascular–endothelial growth factor (VEGF) and transforming growth factor (TGF)- β production and reducing the expression of adhesion molecules. Emorsan(®) Gel, by its ability to inhibit free radicals, could reduce local inflammation and oxidative stress, thus enhancing the speed of wound healing.
format Online
Article
Text
id pubmed-9101165
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91011652022-05-14 Evaluation of a Gel Containing a Propionibacterium Extract in an In Vivo Model of Wound Healing M., Campolo G., Gallo F., Roviello A., Ardizzone M., La Torre A., Filippone M., Lanza S., Cuzzocrea L., Siroli E., Esposito Int J Mol Sci Article Inappropriate wound healing (WH) management can cause significant comorbidities, especially in patients affected by chronic and metabolic diseases, such as diabetes. WH involves several different, partially overlapping processes, including hemostasis, inflammation, cell proliferation, and remodeling. Oxidative stress in WH contributes to WH impairment because of the overexpression of radical oxygen species (ROS) and nitrogen species (RNS). This study aimed to evaluate the in vitro antioxidative action of a gel containing a Propionibacterium extract (Emorsan(®) Gel) and assess its skin re-epithelialization properties in a mouse model of WH. The scavenging effects of the bacterial extract were assessed in vitro through the ABTS and DPPH assays and in L-929 murine fibroblasts. The effects of the Emorsan(®) Gel were studied in vivo in a murine model of WH. After WH induction, mice were treated daily with vehicle or Emorsan(®) Gel for 6 or 12 days. According to the in vitro tests, the Propionibacterium extract exerted an inhibitory effect on ROS and RNS, consequently leading to the reduction in malondialdehyde (MDA) and nitrite levels. Before proceeding with the in vivo study, the Emorsan(®) Gel was verified to be unabsorbed. Therefore, the observed effects could be ascribed to a local action. The results obtained in vivo showed that through local reduction of oxidative stress and inflammation (IL-1β, TNF-α), the Emorsan(®) Gel significantly reduced the infiltration of mast cells into the injured wound, leading to the amelioration of symptoms such as itch and skin irritation. Therefore, the Emorsan(®) Gel improved the speed and percentage of wound area closure by improving the tissue remodeling process, prompting vascular–endothelial growth factor (VEGF) and transforming growth factor (TGF)- β production and reducing the expression of adhesion molecules. Emorsan(®) Gel, by its ability to inhibit free radicals, could reduce local inflammation and oxidative stress, thus enhancing the speed of wound healing. MDPI 2022-04-24 /pmc/articles/PMC9101165/ /pubmed/35563099 http://dx.doi.org/10.3390/ijms23094708 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
M., Campolo
G., Gallo
F., Roviello
A., Ardizzone
M., La Torre
A., Filippone
M., Lanza
S., Cuzzocrea
L., Siroli
E., Esposito
Evaluation of a Gel Containing a Propionibacterium Extract in an In Vivo Model of Wound Healing
title Evaluation of a Gel Containing a Propionibacterium Extract in an In Vivo Model of Wound Healing
title_full Evaluation of a Gel Containing a Propionibacterium Extract in an In Vivo Model of Wound Healing
title_fullStr Evaluation of a Gel Containing a Propionibacterium Extract in an In Vivo Model of Wound Healing
title_full_unstemmed Evaluation of a Gel Containing a Propionibacterium Extract in an In Vivo Model of Wound Healing
title_short Evaluation of a Gel Containing a Propionibacterium Extract in an In Vivo Model of Wound Healing
title_sort evaluation of a gel containing a propionibacterium extract in an in vivo model of wound healing
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101165/
https://www.ncbi.nlm.nih.gov/pubmed/35563099
http://dx.doi.org/10.3390/ijms23094708
work_keys_str_mv AT mcampolo evaluationofagelcontainingapropionibacteriumextractinaninvivomodelofwoundhealing
AT ggallo evaluationofagelcontainingapropionibacteriumextractinaninvivomodelofwoundhealing
AT froviello evaluationofagelcontainingapropionibacteriumextractinaninvivomodelofwoundhealing
AT aardizzone evaluationofagelcontainingapropionibacteriumextractinaninvivomodelofwoundhealing
AT mlatorre evaluationofagelcontainingapropionibacteriumextractinaninvivomodelofwoundhealing
AT afilippone evaluationofagelcontainingapropionibacteriumextractinaninvivomodelofwoundhealing
AT mlanza evaluationofagelcontainingapropionibacteriumextractinaninvivomodelofwoundhealing
AT scuzzocrea evaluationofagelcontainingapropionibacteriumextractinaninvivomodelofwoundhealing
AT lsiroli evaluationofagelcontainingapropionibacteriumextractinaninvivomodelofwoundhealing
AT eesposito evaluationofagelcontainingapropionibacteriumextractinaninvivomodelofwoundhealing